cbdMD (YCBD) has released an update to notify the public and investors about an entry into a material definitive agreement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
On February 1, 2024, cbdMD, Inc. entered into an agreement with five institutional investors, raising $1,250,000 through issuing convertible promissory notes totaling $1,541,666. These notes, bearing 8% annual interest and maturing on July 30, 2025, are convertible into common stock at an initial price of $0.684 per share, with provisions for price adjustments and a prepayment option subject to a premium. The agreement includes a Beneficial Ownership Limitation, ensuring investors do not exceed specific ownership thresholds, and obliges the company to seek shareholder approval for issuing excess shares. Additionally, the company secured a Registration Rights Agreement to facilitate the resale of conversion shares.
For further insights into YCBD stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.